Author

S. Dolff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:flow cytometry· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

K. Paniskaki· 2 shared N. Babel· 2 shared O. Witzke· 2 shared T. Westhoff· 2 shared A. Gaeckler· 1 shared A. Krawczyk· 1 shared A. Limmer· 1 shared C. Scheibenbogen· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. Paniskaki

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome

K. Paniskaki, M. Konik, M. Anft, H. Heidecke, T. Meister, S. Pfaender, A. Krawczyk, M. Zettler, J. Jäger, A. Gaeckler, S. Dolff, T. Westhoff, H. Rohn, U. Stervbo, C. Scheibenbogen, , N. Babel

This study identifies increased migratory CD8+ T cells and low avidity SARS-CoV-2 reactive responses in post-acute COVID-19 syndrome patients compared to healthy convalescents.

bioRxiv · Dec 3, 2022 · PreprintImmunology

Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients

J. Westmeier, K. Paniskaki, Z. Karaköse, T. Werner, K. Sutter, S. Dolff, M. Overbeck, A. Limmer, J. Liu, X. Zheng, T. Brenner, M. M. Berger, O. Witzke, M. Trilling, M. Lu, , G. Zelinskyy

This study examines CD8+ T cell cytotoxicity in mild COVID-19 patients, finding reduced cytotoxic potential in elderly individuals over 80 years old.

bioRxiv · Aug 21, 2020Immunology